bioRxivCancer BiologyPreprint
SOCS1 expression in prostate epithelial cells is essential for tissue homeostasis and tumor suppression
Awais Ullah IhsaniD, Mozhdeh Namvarpour, Mohammad MoradzadiD, Anny Armas Cayarga, Evelyne Ng Kwan Lim, Diya Binoy JosephiD, Stephanie Petkiewicz, Éric MasséiD, Akihiko YoshimuraiD, Gerardo FerbeyreiD, Alfredo MenéndeziD, Sheela RamanathaniD, Subburaj IlangumaraniD
Abstract
Suppressor of cytokine signaling 1 (SOCS1) negative regulates inflammatory cytokine production and attenuates oncogenic growth factor signaling pathways. Reduced SOCS1 protein expression in human prostate cancer correlates with greater disease severity. To define the physiological functions of SOCS1 functions in the prostate, we conditionally ablated Socs1 in prostate epithelial cells of C57BL/6 mice. These Socs1{Delta}PE mice exhibited normal prostate development, maturation and lobular architecture. However, adult Socs1{Delta}PEmice developed progressive epithelial hyperplasia and inflammatory cell infiltration that were temporally and spatially distinct. SOCS1-deficient prostate showed increased epithelial cell proliferation and elevated oxidative stress markers, and prostate organoids recapitulated this hyperplasia phenotype. Diet-induced obesity exacerbated both hyperplasia and inflammation in SOCS1-deficient prostate. Upon transurethral infection with uropathogenic Escherichia coli UPEC1677 expressing the genotoxin colibactin, Socs1{Delta}PE mice developed invasive prostate cancer with complete loss of lobular architecture, whereas control mice developed hyperplasia and pre-neoplastic lesions. In vitro, SOCS1-deficient prostate organoid-derived epithelial cells exhibited increased DNA damage following exposure to UPEC1677. Deletion of the colibactin biosynthetic gene clbP in UPEC1677 abolished its ability to induce DNA damage in SOCS1-deficient cells and to drive prostate cancer in vivo. Proteomic analysis of prostate organoids revealed dysregulation of basal and luminal epithelial lineage markers and signaling pathway proteins that could promote neoplasia in SOCS1-deficient cells. Collectively, these findings establish an essential, epithelial cell-intrinsic role for SOCS1 in maintaining prostate tissue homeostasis by restraining proliferation, regulating lineage plasticity, limiting inflammation and oxidative stress, and conferring protection against genotoxic injury and neoplastic transformation.
- organism: mouse
- assay: proteomics
- research focus: cancer & tumor microenvironment
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Secreted spermidine synthase reveals a paracrine role for PGC1a-induced growth suppression in prostate cancer
Ariane Schaub-Clerigué, Ivana Heřmanová, … Verónica Torrano·Cell Death and DiseasePeer-reviewed·Apr 23, 2025
- JUN mediates senescence and immune cell recruitment to prevent prostate cancer progression
- FOXP2 confers oncogenic effects in prostate cancer through activating MET signalling
- Siglec-15 is a glyco-immune checkpoint in prostate cancer regulating immune evasion and metastasis
Nicoll Matthews, F. Zeng, … Jennifer Munkley·bioRxiv·Aug 10, 2026
- Intermediate basal cell population in prostate homeostasis and cancer initiation
Wangxin Guo, Xiaoyu Zhang, … Dong Gao·bioRxiv·May 12, 2023
- The Establishment of Prostate-specific, SKP2 Humanized Mice by CRISPR Knock-in Method Reveals Neoplastic Initiation and Microenvironmental Reprogramming
Liankun Song, Yurong Song, … Xiaolin Zi·OncogenePeer-reviewed·Aug 1, 2026